Prediction of response to recombinant human erythropoietin (r-HuEPO/epoetin-alpha) therapy in cancer patients.
Henry
D
D
Abels
R
R
Larholt
K
K
D000740:Anemia / Q000097:blood / Q000628:therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D017701:Reticulocyte Count
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin